Cowen downgraded Endo Health (NASDAQ: ENDP) from Neutral to Underperform.

This article: 58 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE